from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0519c/-

LFCtreatmentdescriptionclass of inhibitor

-0.499

Amikacinug/mL Amikacintranslation

0.933

Cap5-10ug/mL Capreomycintranslation

0.238

Rox10-50 ug/mL Roxithromycintranslation

0.670

SM2-5 ug/mL Streptomycintranslation

-0.221

Tet5-10 ug/mL Tetracyclinetranslation

-0.282

Rif0.2-5ug/mL Rifampicintranscription

0.116

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.700

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.216

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.748

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.582

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.373

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.346

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.151

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.405

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.494

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.272

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.103

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.183

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.589

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.377

KCN5-20 ug/mL Potassium cyaniderespiration

-0.394

NaN30.2-2 mM Sodium aziderespiration

0.115

Nigericin50 uM Nigericinrespiration

-0.729

TRC10-150 ug/mL Triclosanrespiration

-0.944

TRZ10-25 ug/mL Thioridazinerespiration

-1.686

Valinomycin0.5-10 uM Valinomycinrespiration

0.608

ZnSO42 mM ZnSO4respiration

-0.115

menadione6-10 ug/mL Menadionerespiration

0.055

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.861

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.561

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.061

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.721

NRP_1Non-replicating persistence stage 1dosRassociated

1.029

Amp0.2mg/mL AmpicillincellWall

1.037

Cephalexin20-100 ug/mL CephalexincellWall

1.330

Cerulenin0.32-5 ug/mL CerulenincellWall

0.515

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.634

EMB10-20 ug/mL EthambutolcellWall

0.658

Eta12-40 ug/mL EthionamidecellWall

0.813

INH0.2-0.4 ug/mL IsoniazidcellWall

0.064

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.976

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.324

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.025

BZA0.12 mg/mL BenzamidearomaticAmides

0.012

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.306

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.042

H2O24 mM hydrogen peroxideDNAdamaging

0.037

Levo10 ug/mL LevofloxacinDNAdamaging

-0.095

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.224

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.247

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.193

UVUV-irradiationDNAdamaging

-2.584

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.078

Antimycin12.5-50 ug/mL Antimycin A?

1.158

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.211

PA_110-50 ug/mL Antitubercular compound PA-1?

0.501

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.229

PA8240.2-2 ug/mL PA-824?

0.456

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.218

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.610

Verapamil50 uM Verapamil?

0.339

mercaptoethanol2 mM 2-Mercaptoethanol?

1.450

methoxatin10-20 ug/mL Methoxatin?